Official title: A Phase 1, Randomised, Double Blind Placebo-controlled, First Time in Human Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Oral Doses and Food Effect of GSK4024484 in Healthy Adult Participants. Summary: The primary purpose of the study is to characterise the safety of GSK4024484 in healthy participants within a controlled pharmacokinetic (PK) range, and the effect of food on the study intervention. Conditions: Malaria, Falciparum Keywords: First time in human, Safety, Pharmacokinetics, GSK4024484, Healthy adults, Food effect, Single oral doses, Multiple oral doses Study type: INTERVENTIONAL Primary purpose: TREATMENT Phases: PHASE1 Enrollment: 156 (ESTIMATED) Status: RECRUITING Completion: 2026-08-07 (ESTIMATED)
ClinicalTrials.gov published a clinical update in Infectious Disease on 01 Apr 2026.
The item focuses on A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants.
Review the original article for the full source wording and details.